|
PIGX expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.446800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.827400E-01 |
| Normal-vs-Stage2 |
4.839600E-01 |
| Normal-vs-Stage3 |
3.845600E-01 |
| Normal-vs-Stage4 |
3.501600E-01 |
| Stage1-vs-Stage2 |
8.041400E-01 |
| Stage1-vs-Stage3 |
6.624600E-01 |
| Stage1-vs-Stage4 |
6.644200E-01 |
| Stage2-vs-Stage3 |
9.136600E-01 |
| Stage2-vs-Stage4 |
8.269200E-01 |
| Stage3-vs-Stage4 |
8.960600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.032000E-01 |
| Normal-vs-AfricanAmerican |
2.107600E-01 |
| Normal-vs-Asian |
1.054360E-01 |
| Caucasian-vs-AfricanAmerican |
3.864600E-03 |
| Caucasian-vs-Asian |
3.304400E-01 |
| AfricanAmerican-vs-Asian |
8.210000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.484600E-01 |
| Normal-vs-Female |
1.724420E-01 |
| Male-vs-Female |
7.382700E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.790630E-01 |
| Normal-vs-Extreme_Weight |
3.592200E-02 |
| Normal-vs-Obese |
8.706400E-01 |
| Normal-vs-Extreme_Obese |
5.142000E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.751200E-01 |
| Normal_Weight-vs-Obese |
1.146240E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.531040E-01 |
| Extreme_Weight-vs-Obese |
8.561300E-03 |
| Extreme_Weight-vs-Extreme_Obese |
1.335030E-01 |
| Obese-vs-Extreme_Obese |
4.748800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.592600E-01 |
| Normal-vs-Age(41-60Yrs) |
6.747600E-01 |
| Normal-vs-Age(61-80Yrs) |
1.246390E-01 |
| Normal-vs-Age(81-100Yrs) |
1.955370E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.898200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.804200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.979390E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.773920E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.076200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.594000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.705200E-01 |
| Normal-VS-Type2 PRCC |
6.379800E-02 |
| Normal-VS-KIRP CIMP |
4.591000E-01 |
| Normal-VS-Unclassified PRCC |
8.648000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.797000E-03 |
| Type1 PRCC-VS-KIRP CIMP |
6.081800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.307600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.689800E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.492030E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.162800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.021700E-02 |
| Normal-vs-N1 |
8.458800E-01 |
| Normal-vs-N2 |
3.322000E-01 |
| N0-vs-N1 |
8.665700E-02 |
| N0-vs-N2 |
9.723000E-01 |
| N1-vs-N2 |
4.425800E-01 |
|
|
